Penn State Milton S. Hershey Medical Center
Calendar  I  Contact Us  I  Help  I  Search
 
  1-800-243-1455
 

 

 

A to Z Topics

 

A   B   C    D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z

 
   

Lung Cancer

What is it?

The incidence of carcinoma of the lung has risen greatly in all economically developed countries of the world. It now stands as one the most common causes of death from cancer in both men and women. 

Who gets it?

Although carcinoma of the lung is still more common in men than women, the frequency of disease in both sexes has been associated with the introduction of certain environmental factors prevalent such as cigarette smoking, urban air pollution and specific industrial exposure.

What are the symptoms?

Symptoms indicative of a diagnosis of lung cancer may be cough, pneumonia, hemoptysis (coughing up blood), or weight loss. Diagnosis is initially made by a chest x-ray with a follow-up computer tomography scan. The decision-making process for determining surgery is very dependent on preoperative clinical staging. Additionally, this may include bronchoscopy; mediastinoscopy to evaluate mediastinal nodes when indicated, and physiologic assessment of the patient's ability to tolerate a major pulmonary resection. Once clinical staging is accomplished treatment can be defined. Prior to surgery it may be necessary for the patient to undergo pulmonary function testing to assess lung capacity. This is done to determine that there will be enough reserve following the removal of the tumor and a portion of the lung itself. Careful preoperative evaluation assures maximum safety.

Diagnosis

When the diagnosis is established there are several treatment options available to the patient depending upon the stage of the disease. Surgical resection, radiation therapy, chemotherapy, immunotherapy, and supportive care all have roles alone or in combination.

In some instances resection is not an option to the patient due to findings unrelated to the tumor. Ventilatory studies must be done to evaluate at what level impaired function makes resection too hazardous. In addition the patient's cardiac status must be evaluated. Cardiac contraindications include recent myocardial infarct, uncontrolled heart failure or an uncontrollable arrhythmia.

Treatment

Once the patient is cleared for surgical resection, and if the tumor's location permits clear margins, surgery will be performed. Because of the advantages and disadvantages of the various procedures, the selection of the operative procedure for a given patient is not blind adherence to any one operation as the only procedure of choice, but should be determined by the physiologic status of the patient and the topographic extent of the tumor at operation.1

At present, a lobectomy is done more often than is a pneumonectomy. Lobectomy is indicated in carcinoma of the bronchus if:

  1. the growth is relatively peripheral and confined to one lobe (or middle and right lower lobe) - in the case of an upper lobe growth, especially on the right, it is possible to obtain almost as good a clearance of lymphatic glands as by pneumonectomy.
  2. The patient is considered unfit of pneumonectomy because of age or impaired lung function.

The final decision whether to carry out a lobectomy or pneumonectomy must remain until the operation because the growth may be more extensive than anticipated.

Lobectomy is also carried out for bronchiectasis, lung abscess, benign tumors and other miscellaneous conditions.2


This information has been designed as a comprehensive and quick reference guide written by our health care reviewers.  The health information written by our authors is intended to be a supplement to the care provided by your physician.  It is not intended nor implied to be a substitute for professional medical advice. 

Back
 
   



Penn State Milton S. Hershey Medical Center ©2004
This page was last updated on October 31, 2006
Contact Us